Replies to post #39155 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

SHOULD NEURORX PURSUE ANOTHER LUNG-RELATED CLINICAL TRIAL???
[immune checkpoint inhibitor]-pneumonitis in a real-world lung cancer cohort is more common and severe than previously reported.

https://www.cancertherapyadvisor.com/home/cancer-topics/lung-cancer/pneumonitis-lung-cancer-immune-checkpoint-clinical-trial-treatment/

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

https://pubmed.ncbi.nlm.nih.gov/31310589/

INTESTINAL PEPTIDE HEALS LUNG

https://www.gesundheitsindustrie-bw.de/en/article/news/inhalation-intestinal-hormone-vip-helps-against-immunotherapy-induced-pneumonia

[Tiger Money]

Good summary of get long BRPA (especially the cheap warrants BRPAW) and short RLFTF. RLFTF is a sell until it hits single digits. the new study will take 4-6 months minimum and RLFTF will drip down everyday.

Investors do have patience for bios and other stocks that will bloom, but with RLFTF having zero management experience and an AWFUL track record, people won't have the patience anymore. you really think Ram can rally shareholders? He doesn't give a crap about shareholders. look how he has been crapping in GEM's face the whole time. I am surprised they haven't removed him as chairman of the board...